Regulatory T cells in many flavors control asthma

Mucosal Immunology

Volumn 3, Issue 3, 2010, Pages 216-229

  Ray, A ^a   Khare, A ^a   Krishnamoorthy, N ^a   Qi, Z ^a   Ray, P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CALCITRIOL; CORTICOSTEROID DERIVATIVE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MICRORNA; RAPAMYCIN; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; VITAMIN D;

ADULTHOOD; ALLERGIC ASTHMA; ANTIGEN SPECIFICITY; ASTHMA; CELL EXPANSION; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; CONTACT SENSITIZATION; DISEASE CONTROL; DISEASE COURSE; DRUG MECHANISM; DRUG POTENTIATION; EFFECTOR CELL; GENE EXPRESSION; GENE FUNCTION; GROWTH INHIBITION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 77951467736     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.4     Document Type: Review

References (223)

1. Metzger, W. J. et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation. Am. Rev. Respir. Dis. 135, 433-440 ( 1987 ).
2. Gavett, S. H., Chen, X., Finkelman, F. & Wills-Karp, M. Depletion of murine CD4 + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10, 587-593 ( 1994 ).
3. Corrigan, C. J., Hartnell, A. & Kay, A. B. T lymphocyte activation in acute severe asthma. Lancet 1, 1129-1132 ( 1988 ).
4. Wierenga, E. A. et al. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic subjects. J. Immunol. 144, 4651-4656 ( 1990 ).
5. Hamid, Q. et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87, 1541-1546 ( 1991 ).
6. Robinson, D. S. et al. Predominant T H2-like bronchoalveolar Tlymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304 ( 1992 ).
7. Kay, A. B. et al. Messenger RNA expression of the cytokine gene cluster IL-3, IL-4, IL-5 and GM-CSF in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173, 775-778 ( 1991 ).
8. Barrett, N. A. & Austen, K. F. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 31, 425-437 ( 2009 ).
9. Barnes, P. J. New molecular targets for the treatment of neutrophilic diseases. J. Allergy Clin. Immunol. 119, 1055-1062 ; quiz 1063-11054 ( 2007 ). (Pubitemid 46654167)
10. Bullens, D. M. et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7, 135 ( 2006 ).
11. Hellings, P. W. et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28, 42-50 ( 2003 ).
12. Molet, S. et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108, 430-438 ( 2001 ). (Pubitemid 32881066)
13. McKinley, L. et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089-4097 ( 2008 ).
14. Owen, R. D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102, 400-401 ( 1945 ).
15. Billingham, R. E., Brent, L. & Medawar, P. B. Actively acquired tolerance of foreign cells. Nature 172, 603-606 ( 1953 ).
16. Strachan, D. P. Hay fever, hygiene, and household size. BMJ 299, 1259-1260 ( 1989 ).
17. van den Biggelaar, A. H. et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356, 1723-1727 ( 2000 ).
18. Yazdanbakhsh, M., Kremsner, P. G. & van Ree, R. Allergy, parasites, and the hygiene hypothesis. Science 296, 490-494 ( 2002 ).
19. Wilson, M. S. et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med. 202, 1199-1212 ( 2005 ). (Pubitemid 41586951)
20. McGuirk, P. & Mills, K. H. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23, 450-455 ( 2002 ). (Pubitemid 35015189)
21. Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 ( 2007 ).
22. Jankovic, D. et al. Conventional T-bet(+)Foxp3( - ) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 ( 2007 ). (Pubitemid 46294544)
23. Kursar, M. et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178, 2661-2665 ( 2007 ). (Pubitemid 46333142)
24. Berg, D. J. et al. Enterocolitis and colon cancer in interleukin-10- deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98, 1010-1020 ( 1996 ).
25. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 ( 1993 ). (Pubitemid 23320290)
26. Li, M. O., Sanjabi, S. & Flavell, R. A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25, 455-471 ( 2006 ). (Pubitemid 44354214)
27. Dutta, P. & Burlingham, W. J. Tolerance to noninherited maternal antigens in mice and humans. Curr. Opin. Organ Transplant 14, 439-447 ( 2009 ).
28. Mold, J. E. et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562-1565 ( 2008 ).
29. Verhasselt, V. et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat. Med. 14, 170-175 ( 2008 ). (Pubitemid 351214558)
30. Polte, T. & Hansen, G. Maternal tolerance achieved during pregnancy is transferred to the offspring via breast milk and persistently protects the offspring from allergic asthma. Clin. Exp. Allergy 38, 1950-1958 ( 2008 ).
31. Holt, P. G., Strickland, D. H., Wikstrom, M. E. & Jahnsen, F. L. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8, 142-152 ( 2008 ).
32. Sly, P. D. et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 372, 1100-1106 ( 2008 ).
33. Torgerson, T. R. & Ochs, H. D. Regulatory T cells in primary immunodeficiency diseases. Curr. Opin. Allergy Clin. Immunol. 7, 515-521 ( 2007 ). (Pubitemid 350076447)
34. Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 ( 1997 ). (Pubitemid 27458961)
35. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 ( 2001 ).
36. Torgerson, T. R. & Ochs, H. D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J. Allergy Clin. Immunol. 120, 744-750 ; quiz 751-1742 ( 2007 ).
37. Gambineri, E., Torgerson, T. R. & Ochs, H. D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430-435 ( 2003 ). (Pubitemid 36774255)
38. Zuidgeest, M. G. et al. Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv. Res. 8, 16 ( 2008 ).
39. Gambineri, E. et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J. Allergy Clin. Immunol. 122, 1105-1112.e1 ( 2008 ).
40. Caudy, A. A., Reddy, S. T., Chatila, T., Atkinson, J. P. & Verbsky, J. W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119, 482-487 ( 2007 ).
41. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 ( 2008 ). (Pubitemid 351707693)
42. Akdis, M. et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567-1575 ( 2004 ). (Pubitemid 38780411)
43. Meiler, F. et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205, 2887-2898 ( 2008 ).
44. Ito, T. et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28, 870-880 ( 2008 ).
45. Akbari, O., DeKruyff, R. H. & Umetsu, D. T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2, 725-731 ( 2001 ). (Pubitemid 32747162)
46. Akbari, O. et al. Antigen-specific regulatory T cells develop via the ICOSICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8, 1024-1032 ( 2002 ). (Pubitemid 35033708)
47. Kearley, J., Barker, J. E., Robinson, D. S. & Lloyd, C. M. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202, 1539-1547 ( 2005 ). (Pubitemid 41746600)
48. Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 ( 2008 ).
49. Campbell, J. D. et al. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med. 206, 1535-1547 ( 2009 ).
50. McMenamin, C., Pimm, C., McKersey, M. & Holt, P. G. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 265, 1869-1871 ( 1994 ). (Pubitemid 24324243)
51. Ostroukhova, M. et al. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J. Clin. Invest. 116, 996-1004 ( 2006 ).
52. Ostroukhova, M. et al. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Invest. 114, 28-38 ( 2004 ). (Pubitemid 39071641)
53. Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933 ( 2005 ). (Pubitemid 40979732)
54. Lewkowich, I. P. et al. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202, 1549-1561 ( 2005 ).
55. Strickland, D. H. et al. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J. Exp. Med. 203, 2649-2660 ( 2006 ).
56. Chen, W. et al. Conversion of peripheral CD4+CD25 - naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 ( 2003 ).
57. Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N. & Lafaille, J. J. CD25 - T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173, 7259-7268 ( 2004 ).
58. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 ( 2004 ). (Pubitemid 38685731)
59. Cobbold, S. P. et al. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172, 6003-6010 ( 2004 ). (Pubitemid 38621201)
60. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 ( 2005 ). (Pubitemid 43045633)
61. Curotto de Lafaille, M. A. et al. Adaptive Foxp3+ regulatory T celldependent and-independent control of allergic inflammation. Immunity 29, 114-126 ( 2008 ).
62. Lathrop, S. K., Santacruz, N. A., Pham, D., Luo, J. & Hsieh, C. S. Antigenspecific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205, 3105-3117 ( 2008 ).
63. Aranda, R. et al. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J. Immunol. 158, 3464-3473 ( 1997 ). (Pubitemid 127484068)
64. Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. & Coffman, R. L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461-1471 ( 1993 ). (Pubitemid 23325202)
65. Izcue, A., Coombes, J. L. & Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 ( 2006 ). (Pubitemid 44116713)
66. Uhlig, H. H. et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177, 5852-5860 ( 2006 ).
67. Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 ( 2007 ).
68. Noverr, M. C., Falkowski, N. R., McDonald, R. A., McKenzie, A. N. & Huffnagle, G. B. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73, 30-38 ( 2005 ).
69. Hisbergues, M. et al. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clin. Exp. Allergy 37, 1286-1295 ( 2007 ). (Pubitemid 47372298)
70. Feleszko, W. et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 37, 498-505 ( 2007 ). (Pubitemid 46537735)
71. Karimi, K., Inman, M. D., Bienenstock, J. & Forsythe, P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 179, 186-193 ( 2009 ).
72. Andersson, J. et al. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 205, 1975-1981 ( 2008 ).
73. Joetham, A. et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J. Immunol. 178, 1433-1442 ( 2007 ).
74. Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 ( 1998 ).
75. Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431 ( 2007 ). (Pubitemid 46559831)
76. Bonertz, A. et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J. Clin. Invest. 119, 3311-3321 ( 2009 ).
77. Pillemer, B. B. et al. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J. Immunol. 183, 155-163 ( 2009 ).
78. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 ( 2006 ).
79. Mangan, P. R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234 ( 2006 ).
80. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 ( 2006 ). (Pubitemid 43214587)
81. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942-949 ( 2007 ). (Pubitemid 47300008)
82. Rose-John, S. & Neurath, M. F. IL-6 trans-signaling: the heat is on. Immunity 20, 2-4 ( 2004 ). (Pubitemid 38134288)
83. Doganci, A. et al. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115, 313-325 ( 2005 ). (Pubitemid 40385473)
84. Dominitzki, S. et al. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J. Immunol. 179, 2041-2045 ( 2007 ).
85. Yang, X. O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358-9363 ( 2007 ).
86. Zhang, D. H., Cohn, L., Ray, P., Bottomly, K. & Ray, A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272, 21597-21603 ( 1997 ). (Pubitemid 27374036)
87. Zheng, W. & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 ( 1997 ). (Pubitemid 27511769)
88. Takaki, H. et al. STAT6 inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 283, 14955-14962 ( 2008 ).
89. Mantel, P. Y. et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5, e329 ( 2007 ).
90. Saito, K. et al. Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J. Immunol. 181, 6889-6897 ( 2008 ).
91. Pace, L., Rizzo, S., Palombi, C., Brombacher, F. & Doria, G. Cutting edge: IL-4-induced protection of CD4+CD25 - Th cells from CD4+CD25+ regulatory T cell-mediated suppression. J. Immunol. 176, 3900-3904 ( 2006 ).
92. Miyara, M. et al. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203, 359-370 ( 2006 ). (Pubitemid 43290845)
93. Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 ( 2009 ).
94. Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772-786 ( 2009 ).
95. Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991 ( 2009 ).
96. Koch, M. A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602 ( 2009 ).
97. Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351-356 ( 2009 ).
98. Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 ( 2007 ). (Pubitemid 47300011)
99. Zhou, L. et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453, 236-240 ( 2008 ). (Pubitemid 351667978)
100. Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56 ( 2008 ).
101. Sallusto, F., Lenig, D., Mackay, C. R. & Lanzavecchia, A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187, 875-883 ( 1998 ). (Pubitemid 28141661)
102. Sasai, Y., Kageyama, R., Tagawa, Y., Shigemoto, R. & Nakanishi, S. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and enhancer of split. Genes Dev. 6, 2620-2634 ( 1992 ). (Pubitemid 23052889)
103. Kageyama, R., Ohtsuka, T. & Tomita, K. The bHLH gene Hes1 regulates differentiation of multiple cell types. Mol. Cells 10, 1-7 ( 2000 ).
104. Eagar, T. N. et al. Notch 1 signaling regulates peripheral T cell activation. Immunity 20, 407-415 ( 2004 ). (Pubitemid 38482119)
105. Nakamura, K., Kitani, A. & Strober, W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor-. J. Exp. Med. 194, 629-644 ( 2001 ). (Pubitemid 32844773)
106. Samon, J. B. et al. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 112, 1813-1821 ( 2008 ).
107. Amsen, D., Antov, A. & Flavell, R. A. The different faces of Notch in Thelper-cell differentiation. Nat. Rev. Immunol. 9, 116-124 ( 2009 ).
108. Becker, J. C., Czerny, C. & Brocker, E. B. Maintenance of clonal anergy by endogenously produced IL-10. Int. Immunol. 6, 1605-1612 ( 1994 ). (Pubitemid 24317870)
109. Enk, A. H., Saloga, J., Becker, D., Mohamadzadeh, M. & Knop, J. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179, 1397-1402 ( 1994 ). (Pubitemid 24091802)
110. Akdis, C. A. et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98, 1676-1683 ( 1996 ).
111. Gri, G. et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29, 771-781 ( 2008 ).
112. Munn, D. H. & Mellor, A. L. Indoleamine 2,3-dioxygenase and tumorinduced tolerance. J. Clin. Invest. 117, 1147-1154 ( 2007 ).
113. Odemuyiwa, S. O. et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J. Immunol. 173, 5909-5913 ( 2004 ).
114. Xu, H. et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation but is not required for tolerance. Proc. Natl. Acad. Sci. USA 105, 6690-6695 ( 2008 ). (Pubitemid 351754568)
115. Montagnoli, C. et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176, 1712-1723 ( 2006 ). (Pubitemid 43134316)
116. Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275 ( 2008 ).
117. Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 ( 2007 ).
118. Wilson, M. S. et al. Suppression of murine allergic airway disease by IL-2: anti-IL-2 monoclonal antibody-induced regulatory T cells. J. Immunol. 181, 6942-6954 ( 2008 ).
119. Liston, A., Lu, L. F., O'Carroll, D., Tarakhovsky, A. & Rudensky, A. Y. Dicerdependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205, 1993-2004 ( 2008 ).
120. Zhou, X. et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205, 1983-1991 ( 2008 ).
121. Kohlhaas, S. et al. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol. 182, 2578-2582 ( 2009 ).
122. Lu, L. F. et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91 ( 2009 ).
123. Rodriguez, A. et al. Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611 ( 2007 ). (Pubitemid 46683148)
124. Thai, T. H. et al. Regulation of the germinal center response by microRNA-155. Science 316, 604-608 ( 2007 ).
125. Baecher-Allan, C., Brown, J. A., Freeman, G. J. & Hafler, D. A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253 ( 2001 ).
126. Fisson, S. et al. Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire. Eur. J. Immunol. 36, 817-827 ( 2006 ).
127. Masteller, E. L., Tang, Q. & Bluestone, J. A. Antigen-specific regulatory T cells - ex vivo expansion and therapeutic potential. Semin. Immunol. 18, 103-110 ( 2006 ). (Pubitemid 43248738)
128. Tran, D. Q., Ramsey, H. & Shevach, E. M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110, 2983-2990 ( 2007 ). (Pubitemid 350006952)
129. Selvaraj, R. K. & Geiger, T. L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol 179, 1390 ( 2007 ).
130. Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 ( 2007 ). (Pubitemid 46256667)
131. Wan, Y. Y. & Flavell, R. A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770 ( 2007 ).
132. Mucida, D. et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 30, 471-472 ; author reply 472-473 ( 2009 ).
133. Wang, J., Huizinga, T. W. & Toes, R. E. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J. Immunol. 183, 4119-4126 ( 2009 ).
134. Xiao, S. et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181, 2277-2284 ( 2008 ).
135. Hill, J. A. et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 29, 758-770 ( 2008 ).
136. Elias, K. M. et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-1020 ( 2008 ).
137. Moore, C. et al. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors. Transplant Proc. 41, 2670-2672 ( 2009 ).
138. Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774 ( 2007 ). (Pubitemid 47236315)
139. Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 ( 2007 ). (Pubitemid 47076203)
140. Ross, A. C. On the sources of retinoic acid in the lung: understanding the local conversion of retinol to retinoic acid. Am. J. Physiol. Lung Cell Mol. Physiol. 286, L247-L248 ( 2004 ).
141. Mucida, D., Park, Y. & Cheroutre, H. From the diet to the nucleus: vitamin A and TGF-beta join efforts at the mucosal interface of the intestine. Semin. Immunol. 21, 14-21 ( 2009 ).
142. Jetten, A. M. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal 7, e003 ( 2009 ).
143. Dirami, G. et al. Lung retinol storing cells synthesize and secrete retinoic acid, an inducer of alveolus formation. Am. J. Physiol. Lung Cell Mol. Physiol. 286, L249-L256 ( 2004 ). (Pubitemid 38129504)
144. Goswami, S. et al. Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma. Nat. Immunol. 10, 496-503 ( 2009 ).
145. Maret, M. et al. Liposomal retinoic acids modulate asthma manifestations in mice. J. Nutr. 137, 2730-2736 ( 2007 ). (Pubitemid 350255305)
146. Dawson, H. et al. Localized Th1-, Th2-, T regulatory cell-, and inflammation-associated hepatic and pulmonary immune responses in Ascaris suum-infected swine are increased by retinoic acid. Infect. Immun. 77, 2576-2587 ( 2009 ).
147. el Mansouri, S. et al. Time-and dose-dependent kinetics of all-transretinoic acid in rats after oral or intravenous administration(s). Drug Metab. Dispos. 23, 227-231 ( 1995 ).
148. Ueki, S. et al. Retinoic acids are potent inhibitors of spontaneous human eosinophil apoptosis. J. Immunol. 181, 7689-7698 ( 2008 ).
149. Dawson, H. D. et al. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 7, 27 ( 2006 ).
150. Iwata, M., Eshima, Y. & Kagechika, H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15, 1017-1025 ( 2003 ). (Pubitemid 36987299)
151. Hypponen, E. et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. NY Acad. Sci. 1037, 84-95 ( 2004 ). (Pubitemid 40299747)
152. Wjst, M. & Dold, S. Genes, factor X, and allergens: what causes allergic diseases? Allergy 54, 757-759 ( 1999 ). (Pubitemid 29333619)
153. Matheu, V., Back, O., Mondoc, E. & Issazadeh-Navikas, S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 112, 585-592 ( 2003 ). (Pubitemid 37108564)
154. Topilski, I. et al. The anti-inflammatory effects of 1,25- dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur. J. Immunol. 34, 1068-1076 ( 2004 ). (Pubitemid 39255985)
155. Sigmundsdottir, H. & Butcher, E. C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 9, 981-987 ( 2008 ).
156. Wjst, M. The vitamin D slant on allergy. Pediatr. Allergy Immunol. 17, 477-483 ( 2006 ). (Pubitemid 44511080)
157. Szatmari, I. & Nagy, L. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 27, 2353-2362 ( 2008 ).
158. Barrat, F. J. et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J. Exp. Med. 195, 603-616 ( 2002 ).
159. O'Garra, A. & Barrat, F. J. In vitro generation of IL-10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by Th1-and Th2-inducing cytokines. Immunol. Lett. 85, 135-139 ( 2003 ). (Pubitemid 36071567)
160. Gorman, S. et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 179, 6273-6283 ( 2007 ).
161. Cantorna, M. T., Hayes, C. E. & DeLuca, H. F. 1,25- Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 128, 68-72 ( 1998 ).
162. Cantorna, M. T., Woodward, W. D., Hayes, C. E. & DeLuca, H. F. 1,25-dihydroxyvitamin D3 is a positive regulator for the two antiencephalitogenic cytokines TGF-beta 1 and IL-4. J. Immunol. 160, 5314-5319 ( 1998 ).
163. Staeva-Vieira, T. P. & Freedman, L. P. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol. 168, 1181-1189 ( 2002 ).
164. O'Kelly, J. et al. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J. Clin. Invest. 109, 1091-1099 ( 2002 ). (Pubitemid 34408584)
165. Wittke, A. et al. Vitamin D receptor expression by the lung microenvironment is required for maximal induction of lung inflammation. Arch. Biochem. Biophys. 460, 306-313 ( 2007 ). (Pubitemid 46589397)
166. Taher, Y. A., van Esch, B. C., Hofman, G. A., Henricks, P. A. & van Oosterhout, A. J. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J. Immunol. 180, 5211-5221 ( 2008 ).
167. Wittke, A., Weaver, V., Mahon, B. D., August, A. & Cantorna, M. T. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 173, 3432-3436 ( 2004 ). (Pubitemid 39142054)
168. Noon, L. Prophylactic inoculation of hay fever. Lancet 1, 1572-1573 ( 1911 ).
169. Noon, L. Prophylactic inoculation against hay fever (historical document). Ann. Allergy 13, 713-716 ; passim ( 1955 ).
170. Francis, J. N., Till, S. J. & Durham, S. R. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111, 1255-1261 ( 2003 ).
171. Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B. & Blaser, K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest 102, 98-106 ( 1998 ). (Pubitemid 28323835)
172. Jutel, M. et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33, 1205-1214 ( 2003 ). (Pubitemid 36609138)
173. O'Hehir, R. E. et al. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am. J. Respir. Crit. Care Med. 180, 936-947 ( 2009 ).
174. Akdis, C. A. & Akdis, M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 123, 735-746 ; quiz 747-1738 ( 2009 ).
175. Wilson, D. R., Torres, L. I. & Durham, S. R. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst. Rev. CD002893 ( 2003 ).
176. Muller, U. et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. 101, 747-754 ( 1998 ). (Pubitemid 28293181)
177. Pereira-Santos, M. C. et al. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy. Clin. Exp. Allergy 38, 291-297 ( 2008 ).
178. Abramson, M. J., Puy, R. M. & Weiner, J. M. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am. J. Respir. Crit. Care Med. 151, 969-974 ( 1995 ).
179. Bousquet, J. & Michel, F. B. Specific immunotherapy in asthma: is it effective? J. Allergy Clin. Immunol. 94, 1-11 ( 1994 ). (Pubitemid 24219652)
180. Bousquet, J., Michel, F. B. & Malling, H. J. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized clinical trials. Am. J. Respir. Crit. Care Med. 152, 1737-1738 ( 1995 ).
181. Abramson, M. J., Puy, R. M. & Weiner, J. M. Allergen immunotherapy for asthma. Cochrane Database Syst. Rev. CD001186 ( 2003 ).
182. Moller, C. et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J. Allergy Clin. Immunol. 109, 251-256 ( 2002 ). (Pubitemid 34158289)
183. Jacobsen, L. et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62, 943-948 ( 2007 ). (Pubitemid 47037870)
184. Rolland, J. M., Gardner, L. M. & O'Hehir, R. E. Allergen-related approaches to immunotherapy. Pharmacol. Ther. 121, 273-284 ( 2009 ).
185. Bousquet, J., Michel, F. B. & Vignola, A. M. Allergen immunotherapy: therapeutic vaccines for asthma. Clin. Allergy Immunol. 18, 511-528 ( 2004 ).
186. Larche, M., Akdis, C. A. & Valenta, R. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6, 761-771 ( 2006 ). (Pubitemid 44453462)
187. Akdis, M. & Akdis, C. A. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 119, 780-791 ( 2007 ). (Pubitemid 46527830)
188. Broide, D. H. Immunomodulation of allergic disease. Annu. Rev. Med. 60, 279-291 ( 2009 ).
189. Larche, M. & Wraith, D. C. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 11, S69-S76 ( 2005 ). (Pubitemid 40562306)
190. Larche, M. Immunotherapy with peptides. Eur. Ann. Allergy Clin. Immunol. 38, 240-243 ( 2006 ). (Pubitemid 44606240)
191. Larche, M. Peptide immunotherapy for allergic diseases. Allergy 62, 325-331 ( 2007 ). (Pubitemid 46246496)
192. Oldfield, W. L., Kay, A. B. & Larche, M. Allergen-derived T cell peptideinduced late asthmatic reactions precede the induction of antigenspecific hyporesponsiveness in atopic allergic asthmatic subjects. J. Immunol. 167, 1734-1739 ( 2001 ). (Pubitemid 32703177)
193. Oldfield, W. L., Larche, M. & Kay, A. B. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360, 47-53 ( 2002 ). (Pubitemid 34756492)
194. Van Overtvelt, L. et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int. Arch. Allergy Immunol. 145, 152-162 ( 2008 ).
195. Verhoef, A., Alexander, C., Kay, A. B. & Larche, M. T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med. 2, e78 ( 2005 ). (Pubitemid 40629472)
196. Alexander, C., Ying, S., A, B. K. & Larche, M. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin. Exp. Allergy 35, 52-58 ( 2005 ). (Pubitemid 40188270)
197. Fellrath, J. M. et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J. Allergy Clin. Immunol. 111, 854-861 ( 2003 ).
198. Tarzi, M. et al. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin. Exp. Allergy 36, 465-474 ( 2006 ).
199. Karagiannidis, C. et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114, 1425-1433 ( 2004 ). (Pubitemid 39575901)
200. John, M. et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colonystimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157, 256-262 ( 1998 ). (Pubitemid 28071290)
201. Stelmach, I., Jerzynska, J. & Kuna, P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin. Exp. Allergy 32, 264-269 ( 2002 ). (Pubitemid 34429606)
202. Hartl, D. et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119, 1258-1266 ( 2007 ).
203. Stock, P., Akbari, O., DeKruyff, R. H. & Umetsu, D. T. Respiratory tolerance is inhibited by the administration of corticosteroids. J. Immunol. 175, 7380-7387 ( 2005 ). (Pubitemid 41713435)
204. Kopf, H., de la Rosa, G. M., Howard, O. M. & Chen, X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int. Immunopharmacol. 7, 1819-1824 ( 2007 ). (Pubitemid 350046435)
205. Coenen, J. J. et al. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplant. 39, 537-545 ( 2007 ).
206. Battaglia, M. et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40-49 ( 2006 ). (Pubitemid 43343297)
207. Battaglia, M. et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338-8347 ( 2006 ).
208. Keever-Taylor, C. A. et al. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy 9, 144-157 ( 2007 ).
209. Strauss, L. et al. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J. Immunol. 178, 320-329 ( 2007 ).
210. Miyara, M., Wing, K. & Sakaguchi, S. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J. Allergy Clin. Immunol. 123, 749-755 ; quiz 756-1747 ( 2009 ).
211. Long, S. A. & Buckner, J. H. Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells. J. Autoimmun. 30, 293-302 ( 2008 ).
212. Coenen, J. J., Koenen, H. J., van Rijssen, E., Hilbrands, L. B. & Joosten, I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 107, 1018-1023 ( 2006 ).
213. Bocian, K. et al. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs. Nephrol. Dial. Transplant. ( 2009 ).
214. Basu, S., Golovina, T., Mikheeva, T., June, C. H. & Riley, J. L. Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J. Immunol. 180, 5794-5798 ( 2008 ).
215. Qu, Y. et al. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Transpl. Immunol. 17, 153-161 ( 2007 ).
216. Eynott, P. R. et al. Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats. Immunology 109, 461-467 ( 2003 ).
217. Corrigan, C. J. Asthma refractory to glucocorticoids: the role of newer immunosuppressants. Am. J. Respir. Med. 1, 47-54 ( 2002 ).
218. Fujitani, Y. & Trifilieff, A. In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am. J. Respir. Crit. Care Med. 167, 193-198 ( 2003 ). (Pubitemid 36076079)
219. Krymskaya, V. P. Targeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle: rationale and promise. BioDrugs 21, 85-95 ( 2007 ).
220. Pace, L., Pioli, C. & Doria, G. IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression. J. Immunol. 174, 7645-7653 ( 2005 ).
221. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 ( 2003 ). (Pubitemid 36222930)
222. Kleinewietfeld, M. et al. CD49d provides access to " untouched " human Foxp3+ Treg free of contaminating effector cells. Blood 113, 827-836 ( 2009 ).
223. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. & Weiner, H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 ( 1994 ). (Pubitemid 24291983)